Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | ECE1 | P42892 | 2/20 | 0.42 |
| ▸ | BMP1 | P13497 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.37 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.37 |
| ▸ | CTSD | P07339 | 2/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30862328 | 0.92 | BMP1 (0.44) | BMP1FOLH1NAALAD2RIMKLACTSD | |
| SCHEMBL4300867 | 0.85 | NOD1 (0.44) | NOD1ECE1BMP1KMT2AFOLH1 | |
| SCHEMBL30682563 | 0.85 | GNPAT (0.43) | NOD1ECE1BMP1KMT2AFOLH1 | |
| SCHEMBL31265329 | 0.85 | ECE1 (0.57) | ECE1KMT2ACA2CA1CTSD | |
| SCHEMBL29389004 | 0.84 | SLC15A2 (0.51) | NOD1FOLH1SLC15A2 | |
| SCHEMBL17305537 | 0.84 | ECE1 (0.43) | NOD1ECE1BMP1KMT2AFOLH1 | |
| SCHEMBL30906694 | 0.83 | FOLH1 (0.45) | NOD1FOLH1NAALAD2RIMKLACTSD | |
| SCHEMBL31243864 | 0.83 | BACE1 (0.52) | CTSDBACE1 | |
| SCHEMBL268801 | 0.83 | KMT2A (0.49) | NOD1KMT2AFOLH1CA2CA1 | |
| SCHEMBL150160 | 0.83 | KMT2A (0.49) | NOD1KMT2AFOLH1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2488 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-116355945-B | Application of MYB3R1 gene in regulation and control of root nodule number of nodule plant | Center for excellence and innovation in molecular plant science, Chinese Academy of Sciences (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-115433273-B | Anti-novel coronavirus rabbit recombinant monoclonal antibody with neutralization activity and application thereof | 苏州缔码生物科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-115335392-B | Inhibition of shade-avoidance response in plants | 成对植物服务股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-117285644-B | Phase change regulating element and application thereof | 清华大学 | 2026-05-15 | — | — | CN | disclosed |
| US-12617850-B2 | Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-05-05 | — | — | US | disclosed |
| US-12590153-B2 | Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4656723-A1 | LUCIFERASE VARIANT | Kikkoman Corporation (JP) | 2025-12-03 | — | — | EP | disclosed |
| CN-113980981-A | Gene SlECT2 for regulating synthesis of tomato fruit aromatic substances and application thereof | 浙江大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980920-A | Carbon-carbon double bond reductase and application thereof | 湖南正清制药集团股份有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980929-A | Method for secretory expression of pichia pastoris endogenous nicotinamide ribokinase and application thereof | 华熙生物科技股份有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993541-A | Alkaline phosphatase-based oncology therapy | 合成生物制品有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-110066810-B | Tamarix chinensis plasma membrane Na+/H+Antiporter gene and application thereof | 南京农业大学 | 2022-01-25 | — | — | CN | disclosed |
| CN-113967253-A | Immunotherapy by disrupting PD-1/PD-L1 signaling | 百时美施贵宝公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-112553182-B | Alpha-galactosidase with enhanced activity | 东莞泛亚太生物科技有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-107614517-B | Antibodies against infectious diseases | 台北医学大学 | 2022-01-21 | — | — | CN | disclosed |
| CN-109666657-B | Glucose oxidase for improving heat resistance | 东莞泛亚太生物科技有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-107586340-B | Bispecific antibodies specific for T cell activating antigens and tumor antigens and methods of use | 罗切格利卡特公司 | 2022-01-21 | — | — | CN | disclosed |